NCT05580861View on ClinicalTrials.gov

Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2026

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Sulfasalazine

Sulfazalazine 500mg-tablets ; 7 dose levels explored in the phase I part of the trial.

Trial Locations (13)

75010

RECRUITING

AP-HP Hôpital Saint Louis, Paris

75014

RECRUITING

AP-HP Hôpital Cochin, Paris

Unknown

NOT_YET_RECRUITING

CHU Amiens, Amiens

NOT_YET_RECRUITING

Hôpital Avicenne, Bobigny

NOT_YET_RECRUITING

CHU Caen, Caen

RECRUITING

CHU Henri Mondor, Créteil

RECRUITING

Centre Hospitalier Lyon Sud, Lyon, Lyon

NOT_YET_RECRUITING

Hôpital de la Conception, AP-HM, Marseille

RECRUITING

CHU Nice, Nice

NOT_YET_RECRUITING

Centre Henri Becquerel, Rouen

RECRUITING

CHU Tours, Tours

RECRUITING

CH Mignot, Versailles

NOT_YET_RECRUITING

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER